Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC, but targeting mutant KRAS has proved challenging. Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases. Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling. Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies have demonstrated that genetic ablation of KRAS expression leads to cell cycle arrest and death in cell lines and potent tumor regressions in animal models of PDAC (5–7).”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this notion, other complex I inhibitors have shown efficacy as anti-tumor agents (Appleyard et al., 2012; Schockel et al., 2015) and may show selective toxicity against oncogene-ablation resistant cells (Viale et al., 2014) and cancer stem cells (Sancho et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recurrent theme in studies on cancer progression is the increased reliance of cancer cells on OXPHOS in advanced stages of disease.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a mouse pancreatic cancer model, ablating oncogenic Kras from established tumors revealed a fraction of cells that survive and eventually propagate.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Self-citationTransmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationHematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Self-citation
Cited by
Items 601–700 of 1,000
Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges
Maertin, S., Elperin, J. M., Lotshaw, E. M., Sendler, M., Speakman, S., Takakura, K., Reicher, B., Mareninova, O. A., Grippo, P. J., Mayerle, J. V., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00138.2017 · Cited by 31
Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
Smigiel, J. M., Parameswaran, N., & Jackson, M. W. (2018) · Cancers · doi:10.3390/cancers10010014 · Cited by 34
Novel Mitochondria-Targeted Furocoumarin Derivatives as Possible Anti-Cancer Agents
Mattarei, A., Romio, M., Managò, A., Zoratti, M., Paradisi, C., Szabó, I., Leanza, L., & Biasutto, L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00122 · Cited by 32
Gammon, S. T., Pisaneschi, F., Bandi, M. L., Smith, M. G., Sun, Y., Rao, Y., Müller, F. L., Wong, F. C., de Groot, J., Ackroyd, J. J., et al. (2019) · Cells · doi:10.3390/cells8121487 · Cited by 34
Radioresistance of Human Cancers: Clinical Implications of Genetic Expression Signatures
de Mey, S., Dufait, I., & Ridder, M. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.761901 · Cited by 36
Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy
Qin, S., Li, B., Ming, H., Nice, E. C., Zou, B., & Huang, C. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188749 · Cited by 32
Kuo, C., Cheng, C.-T., Hou, P., Lin, Y.-P., Ma, H., Chung, Y., Chi, K. K., Chen, Y., Li, W., Kung, H.-J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8570 · Cited by 33
Metabolic Remodeling Induced by Adipocytes: A New Achilles' Heel in Invasive Breast Cancer?
Attané, C., Milhas, D., Hoy, A. J., & Muller, C. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180426165001 · Cited by 34
RETRACTED ARTICLE: Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer
Xu, C., Wang, X., Zhou, Y., Chen, F., Wang, H., Li, K., Fan, H., Tang, X., Jiang, G., & Zhang, J. (2019) · Oncogene · doi:10.1038/s41388-019-0930-3 · Cited by 30
Self-citationRetractedTargeting dormant micrometastases: rationale, evidence to date and clinical implications
Hurst, R. E., Bastian, A., Bailey‐Downs, L. C., & Ihnat, M. A. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834015624277 · Cited by 32
Wang, Y., Liao, X., Sun, J., Yi, B., Luo, S., Liu, T., Tan, X., Liu, D., Chen, Z., Wang, X., et al. (2018) · Advanced Science · doi:10.1002/advs.201700392 · Cited by 30
Self-citationSun, J., Li, G., Liu, Y., Ma, M., Song, K., Li, H., Zhu, D., Tang, X., Kong, J., & Yuan, X. (2019) · Neoplasia · doi:10.1016/j.neo.2019.10.006 · Cited by 32
Tumor Milieu Controlled by RB Tumor Suppressor
Kitajima, S., Li, F., & Takahashi, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072450 · Cited by 31
Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
Pandkar, M. R., Dhamdhere, S. G., & Shukla, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188553 · Cited by 36
Thomas, E. B., Thankan, R. S., Purushottamachar, P., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N. P., Weber, D. J., & Njar, V. C. O. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23406 · Cited by 35
Metaboloptics: Visualization of the tumor functional landscape via metabolic and vascular imaging
Martinez, A. F., McCachren, S. S., Lee, M., Murphy, H. A., Zhu, C., Crouch, B. T., Martin, H. L., Erkanli, A., Rajaram, N., Ashcraft, K. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22480-w · Cited by 32
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
Du, J., & Qin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367981 · Cited by 33
Subedi, A., Futamura, Y., Nishi, M., Ryo, A., Watanabe, N., & Osada, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.128 · Cited by 31
CLIC1 overexpression is associated with poor prognosis in pancreatic ductal adenocarcinomas
Jia, N., Dong, S., Zhao, G., Gao, H., Li, X., & Zhang, H. (2016) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.154057 · Cited by 29
Mollinedo, F., & Gajate, C. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.06.40 · Cited by 30
Moderate Exercise Modulates Tumor Metabolism of Triple-Negative Breast Cancer
Vulczak, A., Souza, A. D. O., Ferrari, G. D., Azzolini, A. E. C. S., Pereira-da-Silva, G., & Alberici, L. C. (2020) · Cells · doi:10.3390/cells9030628 · Cited by 37
Ambrosini, G., Pozza, E. D., Fanelli, G., Carlo, C. D., Vettori, A., Cannino, G., Cavallini, C., Carmona‐Carmona, C. A., Brandi, J., Rinalducci, S., et al. (2020) · Cells · doi:10.3390/cells9071572 · Cited by 30
Bondarenko, M., Grand, M. L., Shaked, Y., Raviv, Z., Chapuisat, G., Carrère, C., Montero, M.-P., Rossi, M., Pasquier, E., Carré, M., et al. (2021) · Cancers · doi:10.3390/cancers13092239 · Cited by 30
Unfolding the role of autophagy in the cancer metabolism
Pandey, A., Yadav, P., & Shukla, S. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101158 · Cited by 35
Krysztofiak, A., Szymonowicz, K., Hlouschek, J., Xiang, K., Waterkamp, C., Larafa, S., Goetting, I., Vega-Rubín-de-Celis, S., Theiß, C., Matschke, V., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103366 · Cited by 33
A Transient Metabolic State in Melanoma Persister Cells Mediated by Chemotherapeutic Treatments
Karki, P., Angardi, V., Mier, J. C., & Orman, M. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.780192 · Cited by 36
Different Tumor Microenvironments Lead to Different Metabolic Phenotypes
Antonio, M. J., Zhang, C., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_10 · Cited by 32
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer
Delahaye, C., Figarol, S., Pradines, A., Favre, G., Mazières, J., & Calvayrac, O. (2022) · Cancers · doi:10.3390/cancers14112613 · Cited by 34
Targeting autophagy as a therapeutic strategy against pancreatic cancer
Yamamoto, K., Iwadate, D., Kato, H., Nakai, Y., Tateishi, K., & Fujishiro, M. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01889-1 · Cited by 29
PINK1/Parkin-Mediated Mitophagy Promotes Resistance to Sonodynamic Therapy
Song, L., Huang, Y., Hou, X., Yang, Y., Kala, S., Qiu, Z., Zhang, R., & Sun, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493629 · Cited by 29
Pharmacology of ME-344, a novel cytotoxic isoflavone
Zhang, L., Zhang, J., Ye, Z., Townsend, D. M., & Tew, K. D. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.01.005 · Cited by 31
Masuo, H., Kubota, K., Shimizu, A., Notake, T., Miyazaki, S., Yoshizawa, T., Sakai, H., Hayashi, H., & Soejima, Y. (2023) · Cancer Science · doi:10.1111/cas.15962 · Cited by 28
Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic Significance
Stouras, I., Vasileiou, M., Kanatas, P., Tziona, E., Tsianava, C., & Theocharis, S. (2023) · Cells · doi:10.3390/cells12232686 · Cited by 31
Rademaker, G., Costanza, B., Bellier, J., Herfs, M. F., Peiffer, R., Agirman, F., Maloujahmoum, N., Habraken, Y., Delvenne, P., Bellahcène, A., et al. (2019) · Oncogenesis · doi:10.1038/s41389-019-0130-6 · Cited by 29
The PGC-1/ERR network and its role in precision oncology
Vitto, H. D., Bode, A. M., & Dong, Z. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0081-6 · Cited by 33
Iqbal, M. S., Luo, B., Mehmood, R., Alrige, M., & Alharbey, R. (2019) · IEEE Access · doi:10.1109/access.2019.2925041 · Cited by 28
Tumor hypermetabolism confers resistance to immunotherapy
Liu, A. J., & Curran, M. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.009 · Cited by 29
The ER-mitochondria Ca2+ signaling in cancer progression: Fueling the monster
Bustos, G., Ahumada-Castro, U., Silva-Pavez, E., Puebla, A., Lovy, A., & Cárdenas, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.03.006 · Cited by 28
Gurreri, E., Genovese, G., Perelli, L., Agostini, A., Piro, G., Carbone, C., & Tortora, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119313 · Cited by 32
Self-citationExtracellular Signal-Regulated Kinases: One Pathway, Multiple Fates
Deschênes‐Simard, X., Malleshaiah, M. K., & Ferbeyre, G. (2023) · Cancers · doi:10.3390/cancers16010095 · Cited by 31
Liu, C., Chen, L., Yu-wen, C., Chen, Y., Liu, Y., Zhou, Y., Shao, Z., & Yu, K. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101396 · Cited by 40
Koay, E. J., Amer, A. M., Baio, F. E., Ondari, A., & Fleming, J. B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.006 · Cited by 28
Self-citationEscaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
Adachi, Y., Kimura, R., Hirade, K., & Ebi, H. (2021) · Cancers · doi:10.3390/cancers13205081 · Cited by 30
Song, X.-H., Yang, L., Zheng, X., Zhu, Q., Liao, X.-L., Liu, K., Zhang, W., Peng, Q., Zhu, Y., Zhao, L.-Y., et al. (2023) · MedComm · doi:10.1002/mco2.342 · Cited by 32
Zhang, Z., Qiao, Y., Sun, Q., Peng, L., & Sun, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01640-6 · Cited by 31
Ren, J., Ren, B., Liu, X., Cui, M., Fang, Y., Wang, X., Zhou, F., Gu, M., Xiao, R., Bai, J., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216649 · Cited by 32
Cortesi, A., Gandolfi, F., Arco, F., Chiaro, P. D., Valli, E., Polletti, S., Noberini, R., Gualdrini, F., Attanasio, S., Citron, F., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk5386 · Cited by 29
Self-citationStephenson, Z. A., Harvey, R. F., Pryde, K. R., Mistry, S. J., Hardy, R. E., Serreli, R., Chung, I., Allen, T. E. H., Stoneley, M., MacFarlane, M., et al. (2020) · eLife · doi:10.7554/elife.55845 · Cited by 29
Inhibiting Mitochondrial DNA Ligase IIIα Activates Caspase 1–Dependent Apoptosis in Cancer Cells
Sallmyr, A., Matsumoto, Y., Roginskaya, V. Y., Houten, B. V., & Tomkinson, A. E. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3243 · Cited by 27
Han, G., Cui, M., Lu, P., Zhang, T., Yin, R., Hu, J., Chai, J., Wang, J., Gao, K., Liu, W., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.008 · Cited by 31
Cai, L., Hammond, N. G., Tasdogan, A., Alsamraae, M., Yang, C., Cameron, R. B., Quan, P., Solmonson, A., Gu, W., Pachnis, P., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1319 · Cited by 33
Pancreatic cancer from bench to bedside: molecular pathways and treatment options
Kosmidis, C. S., Sapalidis, K. G., Kotidis, E. V., Mixalopoulos, N., Zarogoulidis, P., Tsavlis, D., Baka, S., Man, Y.-G., & Kanellos, J. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.05.11 · Cited by 27
Englinger, B., Laemmerer, A., Moser, P., Kallus, S., Röhrl, C., Pirker, C., Baier, D., Mohr, T. T., Niederstaetter, L., Meier, S. M., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32924 · Cited by 26
Dosch, J. S., Ziemke, E. K., Shettigar, A., Rehemtulla, A., & Sebolt, J. S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2793 · Cited by 28
Role of RHOT1 on migration and proliferation of pancreatic cancer.
Li, Q., Yao, L., Wei, Y., Geng, S., He, C., & Jiang, H. (2015) · Europe PMC (PubMed Central) · Cited by 31
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
Yu, R., Hang, Y., Tsai, H., Wang, D., & Zhu, H. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03329-x · Cited by 31
Metabolic reprogramming in cancer and senescence
Zhang, Y., Tang, J., Jiang, C., Yi, H., Shu, G., Yin, G., & Wang, M. (2025) · MedComm · doi:10.1002/mco2.70055 · Cited by 34
OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer
Uslu, C., Kapan, E., & Lyakhovich, A. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103637 · Cited by 30
Metabolic adaptations of brain metastasis
Parida, P. K., & Malladi, S. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00848-1 · Cited by 34
Guo, Y., Hu, B., Fu, B., & Zhu, H. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153529 · Cited by 25
Metabolic memory underlying minimal residual disease in breast cancer
Shechter, K. R., Kafkia, E., Zirngibl, K., Gawrzak, S., Alladin, A., Machado, D., Lüchtenborg, C., Sévin, D. C., Brügger, B., Patil, K. R., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010141 · Cited by 28
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Corchado‐Cobos, R., García‐Sancha, N., Mendiburu‐Eliçabe, M., Gómez-Vecino, A., Jiménez‐Navas, A., Pérez‐Baena, M. J., Holgado-Madruga, M., Mao, J., Cañueto, J., Castillo‐Lluva, S., et al. (2022) · Cancers · doi:10.3390/cancers14020322 · Cited by 28
Blecha, J., Novais, S. M., Rohlenová, K., Novotná, E., Lettlová, S., Schmitt, S., Zischka, H., Neužil, J., & Rohlena, J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.033 · Cited by 26
Academic Discovery of Anticancer Drugs: Historic and Future Perspectives
Carugo, A., & Draetta, G. F. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055645 · Cited by 30
Self-citationMadonna, M. C., Fox, D. B., Crouch, B. T., Lee, J., Zhu, C., Martinez, A. F., Alvarez, J. V., & Ramanujam, N. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0618 · Cited by 26
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities
Turdo, A., Porcelli, G., D’Accardo, C., Franco, S. D., Verona, F., Forte, S., Giuffrida, D., Memeo, L., Todaro, M., & Stassi, G. (2020) · Cancers · doi:10.3390/cancers12061436 · Cited by 28
Zheng, J., Wang, Q., Chen, J., Cai, G., Zhang, Z., Zou, H., Zou, J. X., Liu, Q., Ji, S., Shao, G., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101519 · Cited by 42
Small Cell Lung Cancer—An Update on Chemotherapy Resistance
Ying, Q., Fan, R., Shen, Y., Chen, B., Zhang, J., Li, Q., & Shi, X. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01245-w · Cited by 26
Metabolic plasticity in pancreatic cancer: The mitochondrial connection
Noemi, G., Abbo, D., Anastasia, B., Costamagna, A., Porporato, P. E., & Martini, M. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102089 · Cited by 31
L-Glucose: Another Path to Cancer Cells
Ono, K., Takigawa, S., & Yamada, K. (2020) · Cancers · doi:10.3390/cancers12040850 · Cited by 28
Dietary intervention as a therapeutic for cancer
Morita, M., Kudo, K., Shima, H., & Tanuma, N. (2020) · Cancer Science · doi:10.1111/cas.14777 · Cited by 28
Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
Ghanbari, F., Fortier, A.-M., Park, M., & Philip, A. (2021) · Cancers · doi:10.3390/cancers13112605 · Cited by 25
Iessi, E., Vona, R., Cittadini, C., & Matarrese, P. (2021) · Biomedicines · doi:10.3390/biomedicines9121942 · Cited by 30
Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer
Mobet, Y., Liu, X., Liu, T., Yu, J., & Yi, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.813581 · Cited by 28
Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2
Jin, X., Li, L., Peng, Q., Gan, C., Gao, L. P., He, S., Tan, S., Pu, W., Liu, Y., Gong, Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104349 · Cited by 25
The metabolic addiction of cancer stem cells
Sahoo, O. S., Pethusamy, K., Srivastava, T. P., Talukdar, J., Alqahtani, M. S., Abbas, M. A. E., Dhar, R., & Karmakar, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.955892 · Cited by 26
Involvement of redox signalling in tumour cell dormancy and metastasis
Puente-Cobacho, B., Varela‐López, A., Quiles, J. L., & Ramírez, L. V. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10077-9 · Cited by 27
PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma
Fontana, F., Macchi, C., Anselmi, M., Rizzuto, A. S., Ruscica, M., & Limonta, P. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166897 · Cited by 28
Sun, L., Moritake, T., Ito, K., Matsumoto, Y., Yasui, H., Nakagawa, H., Hirayama, A., Inanami, O., & Tsuboi, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176162 · Cited by 32
Buckley, A. M., Dunne, M. R., Lynam‐Lennon, N., Kennedy, S. A., Cannon, A., Reynolds, A., Maher, S. G., Reynolds, J. V., Kennedy, B. N., & O'Sullivan, J. N. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.009 · Cited by 24
The Contribution of Mitochondrial Ion Channels to Cancer Development and Progression
Bachmann, M., Pontarin, G., & Szabó, I. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000198 · Cited by 24
Metabolic challengers selecting tumor-persistent cells
Mancini, C., Lori, G., Pranzini, E., & Taddei, M. L. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.11.005 · Cited by 27
Nath, S., & Balling, R. (2024) · Function · doi:10.1093/function/zqae008 · Cited by 24
Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles
Ali, H. A., Karasinska, J. M., Topham, J. T., Johal, D., Kalloger, S. E., Metcalfe, A., Warren, C., Miyagi, A., Tao, L. V., Kevorkova, M., et al. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00357-z · Cited by 24
Metabolic adaptations in cancer progression
Peng‐Winkler, Y., & Fendt, S. (2025) · Physiological Reviews · doi:10.1152/physrev.00037.2024 · Cited by 30
Cruz‐Gregorio, A. (2026) · Metabolites · doi:10.3390/metabo16010060 · Cited by 25
Advances in the Genetics and Biology of Pancreatic Cancer
Aguirre, A. J., & Collisson, E. A. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000286 · Cited by 25
Kalainayakan, S. P., Ghosh, P., Dey, S., FitzGerald, K. E., Sohoni, S. S., Konduri, P. C., Garrossian, M., Liu, L., & Li, Z. (2019) · Scientific Reports · doi:10.1038/s41598-018-38345-1 · Cited by 29
Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells
Cornet-Masana, J. M., Banús‐Mulet, A., Carbo, J. M. C. I., Torrente, M. Á., Guijarro, F., Cuesta‐Casanovas, L., Esteve, J., & Risueño, R. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.021 · Cited by 25
Molecular modulation of autophagy: New venture to target resistant cancer stem cells
Mandhair, H. K., Arambasic, M., Novak, U., & Radpour, R. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i5.303 · Cited by 25
Targeting Cancer Metabolism and Current Anti-Cancer Drugs
Sukjoi, W., Ngamkham, J., Attwood, P. V., & Jitrapakdee, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_2 · Cited by 25
ARRB1 Regulates Metabolic Reprogramming to Promote Glycolysis in Stem Cell-Like Bladder Cancer Cells
Mamouni, K., Kim, J., Lokeshwar, B. L., & Kallifatidis, G. (2021) · Cancers · doi:10.3390/cancers13081809 · Cited by 26
The impact of mitochondria on cancer treatment resistance
van der Merwe, M., van Niekerk, G., Fourie, C., du Plessis, M., & Engelbrecht, A. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00623-y · Cited by 26
HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights
Passaro, E., Papulino, C., Chianese, U., Toraldo, A., Congi, R., Gaudio, N. D., Nicoletti, M. M., Benedetti, R., & Altucci, L. (2021) · Cancers · doi:10.3390/cancers13246280 · Cited by 26
C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response
Wang, Q., Chai, D., Sobhani, N., Sun, N., Neeli, P. K., Zheng, J., & Tian, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1012112 · Cited by 29
Li, X., Ze, X., Zhou, S., Hu, Z., He, C., Jia, Y., Liu, L., Wang, T., Li, J., Xu, S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00058 · Cited by 23
Sousa, M. L., Preto, M., Vasconcelos, V. M., Linder, S. T., & Urbatzka, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00224 · Cited by 23
Reddy, K. R. K., Piyarathna, D. W. B., Park, J. H., Putluri, V., Amara, C. S., Kamal, A. H. M., Xu, J., Kraushaar, D. C., Huang, S., Jung, S. Y., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.172336 · Cited by 24
Metabolic landscape of disseminated cancer dormancy
Drápela, S., Garcia, B. M., Gomes, A. P., & Correia, A. L. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.10.005 · Cited by 27
L’autophagie : le yin et le yang des cancers
Joffre, C., Djavaheri‐Mergny, M., Pattingre, S., & Giuriato, S. (2017) · médecine/sciences · doi:10.1051/medsci/20173303021 · Cited by 26
Metadata
- Authors
- Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., Deem, A. K., Kapoor, A., Yao, W., Brunetto, E., Kang, Y., Yuan, M., Asara, J. M., Wang, Y. A., Heffernan, T. P., Kimmelman, A. C., Wang, H., Fleming, J. B., Cantley, L. C., DePinho, R. A., & Draetta, G. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Weill Cornell Medicine (US)
- IRCCS Ospedale San Raffaele (IT)
- Beth Israel Deaconess Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Viale, Andrea
- Draetta, Giulio F.
- ORCID
- Viale, Andrea
- Pettazzoni, Piergiorgio
- Lyssiotis, Costas A.
- Ying, Haoqiang
- Sánchez, Nora
- Marchesini, Matteo
- Carugo, Alessandro
- Seth, Sahil
- Giuliani, Virginia
- Colla, Simona
- Nezi, Luigi
- Genovese, Giannicola
- Deem, Angela K.
- Yao, Wantong
- Brunetto, Emanuela
- Kang, Ya’an
- Yuan, Min
- Asara, John M.
- Wang, Y. Alan
- Heffernan, Timothy P.
- Kimmelman, Alec C.
- Wang, Huamin
- Fleming, Jason B.
- Cantley, Lewis C.
- DePinho, Ronald A.
- Draetta, Giulio F.
- Venue
- Nature
- Published
- 2014-08-10
- Volume
- 514
- Issue
- 7524
- Pages
- 628-632
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4376130
- OpenAlex
- W2023300506
- Semantic Scholar
- 819eeeb41f6e84dd5c00221a269e91238736c4ad
- Cited by
- 1,259
- References
- 125
- Citations by year
- 2026: 93 · 2025: 72 · 2024: 104 · 2023: 105 · 2022: 119 · 2021: 131 · 2020: 135 · 2019: 114 · 2018: 105 · 2017: 90 · 2016: 99 · 2015: 81 · 2014: 8
- FWCI
- 44.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, CA-16672, CA 016672, P01CA120964, P30CA016672, P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, KRAS mutation, tumor recurrence, oxidative phosphorylation, mitochondrial respiration, cancer stem cells, autophagy, glycolysis, OXPHOS inhibitors, combination therapy
- MeSH terms
- Animals, Autophagy, Cell Survival, Disease Models, Animal, Female, Glycolysis, Lysosomes, Mitochondria, Mutation, Neoplasm Recurrence, Local, Oxidative Phosphorylation, Pancreatic Neoplasms, Recurrence, Neoplastic Stem Cells, Signal Transduction, Gene Expression Regulation, Neoplastic, Genes, p53, Proto-Oncogene Proteins p21(ras), Cell Respiration, Carcinoma, Pancreatic Ductal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.